Precirix, a developer of precision radiopharmaceuticals in oncology, has raised 80 million euros in Series B financing.
Company Information
Company
Precirix
About
PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals…
